Status:
COMPLETED
Predicting Death and ICU Admission in COVID-19 Patients in ED
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
COVID
Eligibility:
All Genders
18+ years
Brief Summary
INTRODUCTION. The novel coronavirus designated SARS-CoV-2, has determined an international outbreak of respiratory illness named Covid-19. Patients with Covid-19 present primarily with fever, myalgia ...
Detailed Description
INTRODUCTION After the first cases identified in Wuhan city (China) on December 2019, the novel coronavirus designated SARS-CoV-2 has caused a global epidemic of respiratory illness named COVID-191. T...
Eligibility Criteria
Inclusion
- COVID 19 confirmed patients.
Exclusion
- \<18 years
- Pregnant women
- Asymptomatic and normal x-ray findings subjects
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 15 2020
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04371562
Start Date
March 1 2020
End Date
April 15 2020
Last Update
May 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Marcello Covino
Roma, RM, Italy, 0068